Second line endocrine treatment of postmenopausal advanced breast cancer. Preliminary endocrine results of a 5-ARM randomized phase II trial of medium vs low dose aminoglutethimide, with or without hydrocortisone vs hydrocortisone alone (EORTC 10861)

✍ Scribed by Bruning, P.F.; Bonfrèr, J.M.G.; Wildiers, J.; Jassem, J.; Beex, L.V.A.M.; Schornagel, J.; Nooijen, W.J.; EORTC Breast Cancer Cooperative,

• Book ID: 122918361
• Publisher: Elsevier Science
• Year: 1990
• Tongue: English
• Weight: 514 KB
• Volume: 37
• Category: Article
• ISSN: 0960-0760
• DOI: 10.1016/0960-0760(90)90459-X